Ornella Marelli

Ornella Marelli

Auto-generated profile, based on publicly available information

Ornella Marelli

Department of Medical Biotechnologies and Translational Medicine, School of Medicine, University of Milan , Milan, Italy

Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2007 in Cancer Research
Verified
Journal Article
Closed access
PDF file
GVGisella Volpe
Gisella Volpe
ACAlessandro Cignetti
Alessandro Cignetti
cristina panuzzocristina panuzzo
cristina panuzzo
MKMirela Kuka
Mirela Kuka
KVKatiuscia Vitaggio
Katiuscia Vitaggio
GSGiuseppe Saglio
Giuseppe Saglio
Imatinib currently represents the standard treatment in the early chronic phase of chronic myelogenous leukemia (CML), thanks to the high percentage of cytogenetic complete remission achieved, but it is yet unclear to what extent it can eradicate leukemia. Therefore, different vaccination strategies have been suggested, mainly based on the exploitment of the junctional peptides spanning the fusion region of the Bcr/Abl proteins. To identify new potential immunologic targets, 63 Philadelphia chromosome–positive patients and 6 BCR/ABL–positive cell lines were tested in nested reverse transcriptase PCR to detect the presence of BCR/ABL transcripts arising from the alternative splicing of the main BCR/ABL transcripts. We could detect BCR/ABL transcripts with junctions between BCR exon 1, 13, or 14 and ABL exon 4 in ∼80% of patients and 84% of cell lines, beside the main fusion transcripts. Translation products of these transcripts were characterized at their COOH terminus by a large amino acid portion derived from the out of frame (OOF) reading of ABL gene. These proteins were detected in BCR/ABL–positive cell lines by immunoprecipitation and immunohistochemistry. Finally, we determined whether OOF-specific CD8+ T cells could be found in the peripheral blood of CML patients and whether they could acquire effector function following in vitro sensitization with OOF-derived peptides predicted to bind to human leucocyte antigen (HLA)-A2 and HLA-A3 molecules. We detected the presence of OOF-specific CD8+ T cells in four of four patients studied, and in one case, these T cells exhibited specific cytotoxic activity against both peptide-pulsed targets and autologous primary CML cells. [Cancer Res 2007;67(11):5300–7]

23 January 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
ARAntonello Emilio Rigamonti
Antonello Emilio Rigamonti
RLRoberto Leoncini
Roberto Leoncini
CCClaudia Casnici
Claudia Casnici
OMOrnella Marelli
Ornella Marelli
ACAlessandra De Col
Alessandra De Col
Alessandro SartorioAlessandro Sartorio
Alessandro Sartorio
Introduction: Proteins, particularly whey proteins, represent the most satiating macronutrient in animals and humans. A dietetic regimen based on proteins enriched preload before eating might be a strategy to counteract obesity. Aims and Methods: The aim of the present study was to evaluate the effects of an isocaloric drink containing whey proteins or maltodextrins (preload) on appetite (satiety/hunger measured by a visual analogue scale or VAS), glucometabolic control (blood glucose/insulin), and anorexigenic gastrointestinal peptides (pancreatic polypeptide or PP, glucagon-like peptide 1 or GLP-1 and peptide YY or PYY) in a cohort of obese young women (n = 9; age: 18.1 ± 3.0 years; body mass index, BMI: 38.8 ± 4.5 kg/m2). After two and a half hours, they were administered with a mixed meal at a fixed dose; satiety and hunger were measured by VAS. Results: Each drink significantly augmented satiety and reduced hunger, and the effects were more evident with whey proteins than maltodextrins. Similarly, there were significant increases in GLP-1 and PYY levels (but not PP) after the ingestion of each drink; these anorexigenic responses were higher with whey proteins than maltodextrins. While insulinemia identically increased after each drink, whey proteins induced a lower glycemic response than maltodextrins. No differences in satiety and hunger were found after the meal, which is presumably due to the late administration of the meal test, when the hypophagic effect of whey proteins was disappearing. Conclusions: While whey proteins actually reduce appetite, stimulate anorexigenic gastrointestinal peptides, and improve glucometabolic homeostasis in young obese women, further additional studies are mandatory to demonstrate their hypophagic effects in obese subjects, when administered as preload before eating.

1 December 2002 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
DLD Lattuada
D Lattuada
CCC Casnici
C Casnici
AVA Venuto
A Venuto
OMO Marelli
O Marelli

1 January 2014 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
CCClaudia Casnici
Claudia Casnici
DLDonatella Lattuada
Donatella Lattuada
NTNoemi Tonna
Noemi Tonna
KCKatia Crotta
Katia Crotta
CSClaudio Storini
Claudio Storini
OMOrnella Marelli
Ornella Marelli
The composition of synovial fluid in rheumatoid arthritis (RA) is complex and strongly influences the microenvironment of joints and it is an inseparable element of the disease. Currently, “in vitro” studies are performed on RA cells cultured in the presence of either recombinant proinflammatory cytokines-conditioned medium or medium alone. In this study, we evaluated the use of synovial fluid, derived from RA patients, as optimal culture condition to perform “in vitro” studies on RA synovial fibroblasts. We observed that synovial fluid is more effective in inducing cell proliferation with respect to TNF-alpha or culture medium alone. Spontaneous apoptosis in fibroblasts was also decreased in response to synovial fluid. The expression of proinflammatory cytokines in the presence of synovial fluid was significantly elevated with respect to cells cultured with TNF-alpha or medium, and the overall morphology of cells was also modified. In addition, modulation of intracellular calcium dynamics elicited in response to synovial fluid or TNF-alpha exposure is different and suggests a role for the purinergic signalling in the modulation of the effects. These results emphasize the importance of using RA synovial fluid in “in vitro” studies involving RA cells, in order to reproduce faithfully the physiopathological environmental characteristic of RA joints.

1 June 1998 in International Journal of Immunopharmacology
Verified
Journal Article
Closed access
CCC Casnici
C Casnici
DLD Lattuada
D Lattuada
CPC Perego
C Perego
PFP Franco
P Franco
OMO Marelli
O Marelli

1 September 1990 in Cancer Letters
Verified
Journal Article
Closed access
GCG. Canti
G. Canti
PFP. Franco
P. Franco
OMO. Marelli
O. Marelli
RCR. Cubeddu
R. Cubeddu
PTPaola Taroni
Paola Taroni
RRR. Ramponi
R. Ramponi